相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma
Sakthi Rajendran et al.
CELL REPORTS (2023)
The roles of extracellular vesicles in the immune system
Edit I. Buzas
NATURE REVIEWS IMMUNOLOGY (2023)
Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma
Jintao Gu et al.
NEURO-ONCOLOGY (2022)
Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer
Yue Wang et al.
CELL DEATH AND DIFFERENTIATION (2022)
High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
Soyoung A. A. Oh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2022)
Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level
Xiao-He Ren et al.
ADVANCED SCIENCE (2022)
Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
Yan Zou et al.
SCIENCE ADVANCES (2022)
Encapsulating Cas9 into extracellular vesicles by protein myristoylation
Joseph Andrew Whitley et al.
JOURNAL OF EXTRACELLULAR VESICLES (2022)
Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release
Rostyslav Horbay et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Self-cleaving guide RNAs enable pharmacological selection of precise gene editing events in vivo
Amita Tiyaboonchai et al.
NATURE COMMUNICATIONS (2022)
CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals
Yang Li et al.
ELIFE (2022)
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
Junfeng Jiang et al.
MOLECULAR CANCER (2022)
Tracking tools of extracellular vesicles for biomedical research
Qisong Liu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
Sofia Parrasia et al.
MOLECULAR PHARMACEUTICS (2022)
SOX8 Knockdown Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting the Notch Signaling Pathway
Zhongbo Du et al.
BIOMED RESEARCH INTERNATIONAL (2022)
Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma
Xiao Liu et al.
FRONTIERS IN PHARMACOLOGY (2022)
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma
Xiangyu Zeng et al.
NATURE CANCER (2022)
Frontiers in the treatment of glioblastoma: Past, present and emerging
Taskeen Iqbal Janjua et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis
Konstantinos Floros et al.
CANCER RESEARCH (2021)
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Leonardo Delello Di Filippo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Current status and recent advances in reirradiation of glioblastoma
Giuseppe Minniti et al.
RADIATION ONCOLOGY (2021)
Ferroptosis, radiotherapy, and combination therapeutic strategies
Guang Lei et al.
PROTEIN & CELL (2021)
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
Christian Moya Gamboa et al.
STAR PROTOCOLS (2021)
Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells
Yicun Wang et al.
SCIENCE ADVANCES (2021)
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Guang Lei et al.
CELL RESEARCH (2020)
Programmable base editing of mutated TERT promoter inhibits brain tumour growth
Xinjian Li et al.
NATURE CELL BIOLOGY (2020)
Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance
Clemente Deligne et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity
Kaijia Zhou et al.
SCIENTIFIC REPORTS (2020)
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
Xiaolong Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
Bo Han et al.
THERANOSTICS (2020)
Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer
Sunwang Xu et al.
NATURE COMMUNICATIONS (2019)
Temozolomide for immunomodulation in the treatment of glioblastoma
Aida Karachi et al.
NEURO-ONCOLOGY (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
Jason B. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Glutathione, Glutaredoxins, and Iron
Carsten Berndt et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
EGFR/EGFRvIII Dual-Targeting Peptide-Mediated Drug Delivery for Enhanced Glioma Therapy
Jiani Mao et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
The role of the low-density lipoprotein receptor-related protein 1 (LRP-1) in regulating blood-brain barrier integrity
Yahui Zhao et al.
REVIEWS IN THE NEUROSCIENCES (2016)
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma
Melissa M. Singh et al.
NEURO-ONCOLOGY (2015)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
Glutathione: a key component of the cytoplasmic labile iron pool
Robert C. Hider et al.
BIOMETALS (2011)
HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
Till Milde et al.
CLINICAL CANCER RESEARCH (2010)